Company Overview and News
PETALING JAYA: Construction firm Mudajaya Group Bhd ’s wholly owned subsidiary, Mudajaya Corp Bhd, has secured RM90mil worth of Islamic financing facilities from Kuwait Finance House (M) Bhd.
KUALA LUMPUR: JF Apex Research expects Mudajaya Group Bhd , EITA Resources Bhd , Hap Seng Consolidated Bhd , 7-Eleven Malaysia Holdings Bhd and Datasonic Group Bhd to be among the stocks to watch on Thursday.
PETALING JAYA: Mudajaya Group Bhd ’s unit, Sinar Kamiri Sdn Bhd, has issued its RM245mil green SRI sukuk wakalah at a coupon rate of between 4.96% and 6.35% per year.
KUALA LUMPUR: BHS Industries , Petronas Dagangan, Samchem Holdings, Mudajaya Group and Dialog Group are among stocks to watch on Monday, according to JF Apex.
Last month, Consortium Zenith said there was no urgency to present its feasibility study on the proposed undersea tunnel connecting Penang island to the mainland. ― Picture by KE OoiKUALA LUMPUR, Nov 11 — Mudajaya Group Bhd’s withdrawal from the proposed undersea tunnel connecting Penang island to the mainland does not pose new obstacles to the project, its main concessionaire Consortium Zenith Construction Sdn Bhd said today.
KUALA LUMPUR, Nov 11 ― Mudajaya Group Bhd has announced its withdrawal from the proposed undersea tunnel connecting Penang island to the mainland, raising new questions with regards to the project's future.
Mudajaya got a letter of award to build the bypass from Bandar Baru Air Itam to Tun Dr Lim Chong Eu Expressway (above).
PETALING JAYA: Mudajaya Group Bhd has bagged an award worth RM1.16bil from Prasarana Malaysia Bhd for construction works relating to the Light Rail Transit Line 3 (LRT3) project from Bandar Utama to Johan Setia.
KUALA LUMPUR: Mudajaya Group Bhd and Al-Salam Real Estate Investment Trust (Reit) are among the stocks to watch on Wednesday, according to JF Apex Research.
PETALING JAYA: Mudajaya Group Bhd has received RM118.6mil contract from KLIAA-KLIACS Consortium to build a 16-storey office tower located in Shah Alam.
MarketWatch: The three major US stock indexes and the Russell 2000 posted record high closes for the second straight day on Tuesday, helped by gains in airlines and as carmakers rose after strong September vehicle sales. The DJIA rose 84.07 points, or 0.37%, to close at 22,641.67, the S&P 500 gained 5.46 points, or 0.22%, to 2,534.58 and the Nasdaq added 15.00 points, or 0.23%, to 6,531.71. - Reuters
MarketWatch: US stock indexes slipped on Thursday as investors braced for a third interest rate hike this year and the United States ordered new sanctions against North Korea. The DJIA fell 53.36 points, or 0.24%, to 22,359.23, the S&P 500 lost 7.64 points, or 0.30%, to 2,500.6 and the Nasdaq dropped 33.35 points, or 0.52%, to 6,422.69. - Reuters
The company said in a July stock exchange filing that the funds raised from the placement exercise will be used to fund the construction of a new power concession asset that was awarded to the company on Dec 21 last year. (Filepic)
MarketWatch: The Dow Jones Industrial Average hit a record closing high on Monday, helped by Boeing, while selling in Facebook, Alphabet and other technology companies checked the S&P 500 and pulled the Nasdaq lower. The DJIA rose 0.28% to end at 21,891.12 points and the S&P 500 lost 0.07% to 2,470.3. The Nasdaq dropped 0.42% to 6,348.12. - Reuters
The construction engineering company said in a Bursa Malaysia announcement that the placement exercise is expected to raise up to RM75.45mil in a maximum scenario, and at least RM67.30mil in a minimum scenario situation
2018-05-21 - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
2018-05-21 - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...